Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 4/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28548128 | 0.84 | NPSR1 (0.37) | HPGDNPSR1GAAMAPTKCNH3 | |
| SCHEMBL15063335 | 0.83 | NPSR1 (0.38) | KMT2AHPGDNPSR1GAAEPHX1 | |
| SCHEMBL28846577 | 0.79 | KMT2A (0.36) | KMT2AHPGDNPSR1GAAEPHX1 | |
| SCHEMBL9850860 | 0.75 | KMT2A (0.41) | KMT2AHPGDNPSR1GAAEPHX1 | |
| Diphenylamine SCHEMBL28718278 | 0.73 | HSD17B10 (0.46) | KMT2AHPGDNPSR1GAAMAPT | |
| SCHEMBL6287324 | 0.72 | KMT2A (0.39) | KMT2AHPGDNPSR1GAAEPHX1 | |
| Diphenylamine SCHEMBL29183344 | 0.72 | HSD17B10 (0.44) | KMT2AHPGDNPSR1GAAMAPT | |
| SCHEMBL28121455 | 0.71 | NPSR1 (0.40) | KMT2AHPGDNPSR1GAAMAPT | |
| SCHEMBL1856484 | 0.70 | TDP1 (0.42) | KMT2AHPGDMAPTKCNH3TSHR | |
| SCHEMBL11097238 | 0.69 | TSHR (0.40) | KMT2AHPGDNPSR1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104673170-A | Long-opening-time primer and preparation method thereof | Beijing tianshan new material technology co ltd | 2015-06-03 | — | — | CN | claimed |
| US-20260048880-A1 | HIGH EFFICIENCY PHARMACEUTICAL FILLING LINE | CORNING INC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-3959180-B1 | PHARMACEUTICAL PACKAGES WITH COATINGS COMPRISING POLYSILAZANE | CORNING INC (US) | 2025-10-15 | — | — | EP | disclosed |
| US-12409103-B2 | Glass articles with low-friction coatings | CORNING INCORPORATED (US) | 2025-09-09 | — | — | US | disclosed |
| US-12391600-B2 | Delamination resistant glass containers with heat-tolerant coatings | CORNING INCORPORATED (US) | 2025-08-19 | — | — | US | disclosed |
| US-12365498-B2 | High efficiency pharmaceutical filling line | CORNING INCORPORATED (US) | 2025-07-22 | — | — | US | disclosed |
| EP-4444665-A1 | CHEMICALLY DURABLE BOROSILICATE GLASS COMPOSITIONS FOR STORING PHARMACEUTICAL COMPOSITIONS AND ARTICLES FORMED THEREFROM | Corning Incorporated (US) | 2024-10-16 | — | — | EP | disclosed |
| CN-118541334-A | Chemically durable borosilicate glass compositions for storage of pharmaceutical compositions and articles formed therefrom | 康宁股份有限公司 | 2024-08-23 | — | — | CN | disclosed |
| US-20240225956-A1 | GLASS CONTAINERS WITH DELAMINATION RESISTANCE AND IMPROVED DAMAGE TOLERANCE | CORNING INCORPORATED (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240197566-A1 | GLASS CONTAINERS WITH IMPROVED STRENGTH AND IMPROVED DAMAGE TOLERANCE | CORNING INCORPORATED (US) | 2024-06-20 | — | — | US | disclosed |
| WO-2014085246-A1 | GLASS CONTAINERS WITH DELAMINATION RESISTANCE AND IMPROVED DAMAGE TOLERANCE | CORNING INCORPORATED (US) | 2014-06-05 | — | — | WO | disclosed |
| US-20140151371-A1 | GLASS CONTAINERS WITH DELAMINATION RESISTANCE AND IMPROVED STRENGTH | CORNING INCORPORATED (US) | 2014-06-05 | — | — | US | disclosed |
| US-20140069886-A1 | DELAMINATION RESISTANT GLASS CONTAINERS WITH HEAT-TOLERANT COATINGS | CORNING INCORPORATED (US) | 2014-03-13 | — | — | US | disclosed |
| US-20140034544-A1 | STRENGTHENED BOROSILICATE GLASS CONTAINERS WITH IMPROVED DAMAGE TOLERANCE | CORNING INCORPORATED (US) | 2014-02-06 | — | — | US | disclosed |
| WO-2014005030-A1 | DELAMINATION RESISTANT GLASS CONTAINERS WITH HEAT-TOLERANT COATINGS | CORNING INCORPORATED (US) | 2014-01-03 | — | — | WO | disclosed |
| US-20140001143-A1 | DELAMINATION RESISTANT GLASS CONTAINERS WITH HEAT-TOLERANT COATINGS | CORNING INCORPORATED | 2014-01-02 | — | — | US | disclosed |
| US-20140001076-A1 | DELAMINATION RESISTANT GLASS CONTAINERS WITH HEAT-TOLERANT COATINGS | CORNING INCORPORATED (US) | 2014-01-02 | — | — | US | disclosed |
| WO-2013130724-A2 | GLASS ARTICLES WITH LOW-FRICTION COATINGS | CORNING INCORPORATED (US) | 2013-09-06 | — | — | WO | disclosed |
| US-20130224407-A1 | Glass Articles With Low-Friction Coatings | CORNING INCORPORATED (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130171456-A1 | Glass Articles With Low-Friction Coatings | CORNING INCORPORATED (US) | 2013-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048880-A1 | HIGH EFFICIENCY PHARMACEUTICAL FILLING LINE | HTR2B, P2RY10, P2RX4 | KMT2A 3956/4885HPGD 4445/4885NPSR1 3512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.